477 related articles for article (PubMed ID: 15079851)
41. Effectiveness and safety of methylphenidate in adult attention deficit hyperactivity disorder in patients with epilepsy: an open treatment trial.
van der Feltz-Cornelis CM; Aldenkamp AP
Epilepsy Behav; 2006 May; 8(3):659-62. PubMed ID: 16504592
[TBL] [Abstract][Full Text] [Related]
42. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
43. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
44. Drugs and children.
Pinkham JR
ASDC J Dent Child; 2002; 69(1):10. PubMed ID: 12119805
[No Abstract] [Full Text] [Related]
45. [Methylphenidate of retard forms in children and adolescents with ADHD - an overview].
Pelz R; Banaschewski T; Becker K
Klin Padiatr; 2008; 220(2):93-100. PubMed ID: 18157763
[TBL] [Abstract][Full Text] [Related]
46. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
Aanonsen NO
Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
[TBL] [Abstract][Full Text] [Related]
47. Methylphenidate and narcolepsy: new indication. When modafinil fails.
Prescrire Int; 2001 Feb; 10(51):7-9. PubMed ID: 11503860
[TBL] [Abstract][Full Text] [Related]
48. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction.
Conners CK
Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496
[No Abstract] [Full Text] [Related]
49. Transdermal methylphenidate system: old wine in a new bottle.
Bukstein OG
Expert Opin Drug Metab Toxicol; 2009 Jun; 5(6):661-5. PubMed ID: 19442029
[TBL] [Abstract][Full Text] [Related]
50. [Utilization of methylphenidate(Ritalin) in France].
Frances C; Hoizey G; Millart H; Trenque T
Therapie; 2002; 57(2):189-93. PubMed ID: 12185970
[TBL] [Abstract][Full Text] [Related]
51. ADHD, methylphenidate and driving: does some legislation endanger public health?
Verster JC; Cox DJ
J Psychopharmacol; 2008 May; 22(3):227-9. PubMed ID: 18541623
[No Abstract] [Full Text] [Related]
52. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
53. [Malnutrition in children with DAMP?].
Andersen LL
Ugeskr Laeger; 2009 Mar; 171(10):824. PubMed ID: 19280776
[No Abstract] [Full Text] [Related]
54. [Infantile psychosis secondary to methylphenidate].
Fernández-Fernández MA; Rufo-Campos M; Mateos-Checa R; Muñoz-Cabello B; Madruga-Garrido M; Blanco-Martínez B
Rev Neurol; 2011 Apr; 52(7):446-7. PubMed ID: 21425116
[No Abstract] [Full Text] [Related]
55. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
[TBL] [Abstract][Full Text] [Related]
56. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
57. Attention deficit hyperactivity disorder and substance use disorders.
Szobot CM; Bukstein O
Child Adolesc Psychiatr Clin N Am; 2008 Apr; 17(2):309-23, viii. PubMed ID: 18295148
[TBL] [Abstract][Full Text] [Related]
58. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
[TBL] [Abstract][Full Text] [Related]
59. [Off-label use: the case of methylphenidate (Ritalin)].
Fritze J; Schmauss M
Nervenarzt; 2002 Dec; 73(12):1210-2. PubMed ID: 12599339
[No Abstract] [Full Text] [Related]
60. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
